Search Results 241-250 of 16279 for monoclonal antibody

1. Publications - Angie N. Ton, M.D. - Mayo Clinic

   Ton A, Francis D, Speicher L. COVID-19 Patient Acceptance to Monoclonal Antibody Infusion: A Single Medical Center Experience. South Med J 2021 Aug; 114 (8): ...

2. Sikander Ailawadhi, M.D. - Mayo Clinic Faculty Profiles

   Study topics have included the therapeutic mechanisms of BCL-2 inhibitors, monoclonal antibodies and immunomodulatory agents. These were investigator ...

3. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...

4. 9-13 Q & A Podcast COVID-19 Update - Mayo Clinic News Network

   ... monoclonal antibody therapy in some cases. If you have this treatment, do you still develop your own antibodies and long-term protection? And does having ...

5. Melanoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

6. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma - Mayo Clinic

   Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

7. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

8. Post-traumatic headache: Clinical trial seeks predictors and therapies

   ... monoclonal antibody. That randomization will occur when a participant has experienced post-traumatic headache for 35 to 56 days. Dr. Schwedt notes that ...

9. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

10. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...